Aura Biosciences, Inc. Depreciation
Aura Biosciences, Inc. (AURA) reported Depreciation of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- Aura Biosciences, Inc. depreciation for the quarter ending 2026-06-30 was $300.00K, a 0.00% change year-over-year.
- Aura Biosciences, Inc. depreciation for the quarter ending 2026-03-31 was $274.00K, a 5.84% decline year-over-year.
- Aura Biosciences, Inc. depreciation for the quarter ending 2025-12-31 was $272.00K, a 6.53% decline year-over-year.
- Aura Biosciences, Inc. depreciation for the quarter ending 2025-09-30 was $300.00K, a 0.00% change year-over-year.
- Aura Biosciences, Inc. depreciation for fiscal 2025 was $1.13M, a 7.69% decline from fiscal 2024.
- Aura Biosciences, Inc. depreciation for fiscal 2024 was $1.22M, a 5.56% decline from fiscal 2023.
- Aura Biosciences, Inc. depreciation for fiscal 2023 was $1.29M, a 10.03% increase from fiscal 2022.
- Aura Biosciences, Inc. depreciation for fiscal 2022 was $1.18M, a 41.64% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-11 | $534.00K 10-Q · filed 2026-08-11 | $846.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $274.00K 10-Q · filed 2026-05-11 | $546.00K derived: sum of 2 quarters · filed 2026-05-11 | $846.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $572.00K derived: sum of 2 quarters · filed 2026-03-30 | $872.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.13M 10-K · filed 2026-03-30 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-13 | $600.00K derived: sum of 2 quarters · filed 2026-08-11 | $857.00K 10-Q · filed 2025-11-13 | $1.18M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-11 | $577.00K 10-Q · filed 2026-08-11 | $882.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.18M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $291.00K 10-Q · filed 2026-05-11 | $582.00K derived: sum of 2 quarters · filed 2026-05-11 | $882.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.18M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $591.00K derived: sum of 2 quarters · filed 2026-03-30 | $891.00K derived: sum of 3 quarters · filed 2026-03-30 | $1.22M 10-K · filed 2026-03-30 |
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-13 | $600.00K derived: sum of 2 quarters · filed 2025-11-13 | $932.00K 10-Q · filed 2025-11-13 | $1.23M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-13 | $619.00K 10-Q · filed 2025-08-13 | $930.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.33M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $306.00K 10-Q · filed 2025-05-15 | $630.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.03M derived: sum of 3 quarters · filed 2025-05-15 | $1.33M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $724.00K derived: sum of 2 quarters · filed 2025-03-24 | $1.02M derived: sum of 3 quarters · filed 2025-03-24 | $1.29M 10-K · filed 2025-03-24 |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-12 | $700.00K derived: sum of 2 quarters · filed 2024-11-12 | $971.00K 10-Q · filed 2024-11-12 | $1.35M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-08 | $628.00K 10-Q · filed 2024-08-08 | $951.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.25M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $328.00K 10-Q · filed 2024-05-09 | $651.00K derived: sum of 2 quarters · filed 2024-05-09 | $951.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.25M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $623.00K derived: sum of 2 quarters · filed 2024-03-27 | $923.00K derived: sum of 3 quarters · filed 2024-03-27 | $1.18M 10-K · filed 2024-03-27 |
| 2022-09-30 | $300.00K 10-Q · filed 2023-11-09 | $600.00K derived: sum of 2 quarters · filed 2023-11-09 | $854.00K 10-Q · filed 2023-11-09 | $1.09M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $300.00K 10-Q · filed 2023-08-09 | $552.00K 10-Q · filed 2023-08-09 | $786.00K derived: sum of 3 quarters · filed 2023-08-09 | $986.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $256.00K 10-Q · filed 2023-05-11 | $486.00K derived: sum of 2 quarters · filed 2023-05-11 | $686.00K derived: sum of 3 quarters · filed 2023-05-11 | $886.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $430.00K derived: sum of 2 quarters · filed 2023-03-15 | $630.00K derived: sum of 3 quarters · filed 2023-03-15 | $831.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-10 | $400.00K derived: sum of 2 quarters · filed 2022-11-10 | $601.00K 10-Q · filed 2022-11-10 | $811.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-11 | $385.00K 10-Q · filed 2022-08-11 | $611.00K derived: sum of 3 quarters · filed 2022-08-11 | $811.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $185.00K 10-Q · filed 2022-05-12 | $411.00K derived: sum of 2 quarters · filed 2022-05-12 | $611.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $426.00K derived: sum of 2 quarters · filed 2022-03-23 | $831.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-24 | $605.00K 10-Q · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |